Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$154.67 - $290.89 $6.47 Million - $12.2 Million
41,823 New
41,823 $6.67 Million
Q1 2022

May 16, 2022

SELL
$194.8 - $275.7 $2.51 Million - $3.56 Million
-12,900 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $3.29 Million - $4.11 Million
12,900 New
12,900 $3.43 Million
Q2 2021

Aug 16, 2021

SELL
$225.52 - $304.06 $425,330 - $573,457
-1,886 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$235.95 - $293.05 $445,001 - $552,692
1,886 New
1,886 $492,000
Q3 2020

Nov 16, 2020

SELL
$192.55 - $236.59 $990,092 - $1.22 Million
-5,142 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$159.17 - $224.73 $580,492 - $819,590
-3,647 Reduced 41.5%
5,142 $999,000
Q1 2020

May 15, 2020

BUY
$130.01 - $216.44 $806,452 - $1.34 Million
6,203 Added 239.87%
8,789 $1.46 Million
Q4 2019

Feb 14, 2020

SELL
$144.81 - $186.0 $475,700 - $611,010
-3,285 Reduced 55.95%
2,586 $443,000
Q3 2019

Nov 14, 2019

BUY
$117.35 - $167.95 $178,958 - $256,123
1,525 Added 35.09%
5,871 $968,000
Q2 2019

Aug 14, 2019

SELL
$82.13 - $120.73 $706,810 - $1.04 Million
-8,606 Reduced 66.45%
4,346 $519,000
Q1 2019

May 15, 2019

BUY
$72.44 - $101.87 $87,435 - $122,957
1,207 Added 10.28%
12,952 $1.23 Million
Q4 2018

Feb 14, 2019

SELL
$73.27 - $105.19 $590,922 - $848,357
-8,065 Reduced 40.71%
11,745 $932,000
Q3 2018

Nov 14, 2018

SELL
$81.43 - $108.13 $1.54 Million - $2.05 Million
-18,963 Reduced 48.91%
19,810 $2.1 Million
Q2 2018

Aug 14, 2018

BUY
$83.27 - $101.93 $2.84 Million - $3.48 Million
34,108 Added 731.15%
38,773 $3.32 Million
Q1 2018

May 15, 2018

BUY
$68.49 - $87.2 $319,505 - $406,788
4,665 New
4,665 $404,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.